Authors: Schmaltz, C Alpdogan, O Horndasch, KJ Muriglan, SJ Kappel, BJ Teshima, T Ferrara, JLM Burakoff, SJ van den Brink, MRM

Citation: C. Schmaltz et al., Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect, BLOOD, 97(9), 2001, pp. 2886-2895

Authors: van den Brink, MRM Moore, E Horndasch, KJ Crawford, JM Murphy, GF Burakoff, SJ

Citation: Mrm. Van Den Brink et al., Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease, TRANSPLANT, 70(1), 2000, pp. 184-191

Authors: van den Brink, MRM Moore, E Horndasch, KJ Crawford, JM Hoffman, J Murphy, GF Burakoff, SJ

Citation: Mrm. Van Den Brink et al., Fas-deficient lpr mice are more susceptible to graft-versus-host disease, J IMMUNOL, 164(1), 2000, pp. 469-480